Iritis and Uveitis Follow-up

Updated: Aug 08, 2017
  • Author: Monalisa N Muchatuta , MD, MS; Chief Editor: Gil Z Shlamovitz, MD, FACEP  more...
  • Print

Further Outpatient Care

Follow-up care with an ophthalmologist within 24 hours is imperative.

In the acute phase, cases of uveitis are monitored every 1-7 days with slit-lamp examination and intraocular pressure measurements.

The ophthalmologist tapers steroids and cycloplegics. [19]

When the condition is stable, patients are monitored every 1-6 months.

The FDA recently approved two sustained-release corticosteroid vitreous implants (fluocinolone acetonide [Retisert], dexamethasone [Ozurdex]) for the treatment of inflammation-induced cases of panuveitis, intermediate uveitis, and posterior uveitis. [1] These implants preclude risks associated with systemic steroids and reduce the need for immunosuppressive agents while providing continuous therapy (approximately 30 months). [20, 21] The installation and monitoring of these treatment modalities should be managed by an ophthalmologist. 



An acute rise in intraocular pressure secondary to pupillary block (posterior synechiae), inflammation or topical corticosteroid use is the single most important complication.

Examine all patients presenting with a red eye with a slit lamp to detect the presence of cells or flare.

Consider all other causes of a red eye [22] before uveitis is diagnosed.

An acute rise in intraocular pressure can lead to optic nerve atrophy and permanent vision loss.



Generally, the prognosis for iritis and uveitis is good with appropriate treatment.


Patient Education

For patient education resources, see the Eye and Vision Center. Also, see the patient education articles Anatomy of the Eye and Iritis.